XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 64.63%171.67M | 0.48%63.77M | 1,099.70%43.97M | 4.96%32.86M | 431.84%31.07M | 33.34%104.28M | 57.71%63.47M | -81.78%3.67M | 320.26%31.31M | -43.84%5.84M |
Net income from continuing operations | 117.10%25.53M | -89.17%2.17M | 121.61%16.55M | 112.27%8.2M | 108.71%2.26M | -19.68%-149.26M | 276.09%20.05M | -166.69%-76.61M | -68.62%-66.78M | 42.41%-25.92M |
Operating gains losses | ---- | ---- | ---- | ---- | ---- | --15.51M | --0 | --2.85M | ---- | ---- |
Depreciation and amortization | -2.28%44.89M | 0.22%11.44M | -3.53%11.24M | -8.10%10.87M | 2.70%11.35M | 11.94%45.94M | 9.19%11.41M | 14.26%11.65M | 15.71%11.83M | 8.66%11.05M |
Deferred tax | 114.06%791K | 81.35%-1.05M | --0 | --0 | --1.84M | -290.56%-5.62M | ---5.62M | --0 | --0 | --0 |
Other non cash items | -94.97%2.94M | 201.79%4.15M | -103.50%-1.97M | -102.11%-94K | -57.26%850K | 1,405.69%58.5M | -36.96%-4.08M | 2,064.79%56.13M | 61.03%4.45M | 32.16%1.99M |
Change In working capital | -3,075.78%-10.45M | 6.41%19.65M | 63.50%-6.45M | -232.34%-13.52M | 5.03%-10.12M | -99.11%351K | 2.61%18.47M | -448.13%-17.68M | 517.40%10.22M | -171.96%-10.66M |
-Change in receivables | 60.92%-5.48M | -5.53%-27.91M | 191.05%2.44M | 5.59%-19.54M | 10.40%39.53M | -54.93%-14.02M | 13.21%-26.45M | -181.82%-2.68M | -13.83%-20.7M | -1.44%35.81M |
-Change in prepaid assets | 168.00%2.81M | 65.92%-3.26M | 39.65%5.63M | -76.27%1.65M | 78.03%-1.22M | -84.89%-4.13M | -411.13%-9.56M | -22.80%4.03M | 275.45%6.97M | 15.09%-5.57M |
-Change in payables and accrued expense | -189.59%-7.05M | -23.19%20.81M | -8.00%-6.45M | -42.97%7.67M | -8.93%-29.08M | -32.83%7.87M | 75.31%27.09M | -214.89%-5.97M | 108.81%13.45M | -73.63%-26.7M |
-Change in other current liabilities | 425.69%4.27M | -529.71%-2.61M | 405.58%4.22M | -63.06%140K | 2,323.08%2.52M | -152.63%-1.31M | -111.38%-414K | -68.83%-1.38M | 144.52%379K | 121.62%104K |
-Change in other working capital | -141.81%-4.99M | 17.35%32.61M | -5.31%-12.3M | -134.03%-3.45M | -52.88%-21.87M | -67.39%11.94M | 5.64%27.79M | -49.58%-11.68M | -41.19%10.12M | -1,705.16%-14.3M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 64.63%171.67M | 0.48%63.77M | 1,099.70%43.97M | 4.96%32.86M | 431.84%31.07M | 33.34%104.28M | 57.71%63.47M | -81.78%3.67M | 320.26%31.31M | -43.84%5.84M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 73.97%-46.52M | 257.79%52.97M | 22.06%-64.69M | 113.27%6.9M | -309.69%-41.69M | -347.02%-178.75M | -552.31%-33.57M | -307.04%-83M | -342.33%-52.01M | 71.66%-10.18M |
Capital expenditure reported | 10.81%-14.16M | -31.74%-3.75M | -4.38%-4.13M | 21.65%-3.37M | 38.94%-2.92M | 7.39%-15.88M | 36.74%-2.85M | 13.90%-3.95M | 5.09%-4.31M | -35.60%-4.78M |
Net PPE purchase and sale | 21.55%-3.43M | -222.34%-1.18M | -354.92%-1.34M | 80.27%-280K | 72.87%-620K | 78.58%-4.37M | 94.97%-367K | 94.97%-295K | 65.98%-1.42M | 25.16%-2.29M |
Net business purchase and sale | -7.06%-37.3M | ---103K | ---37.2M | --0 | --0 | ---34.84M | --0 | --0 | ---808K | ---34.03M |
Net investment purchase and sale | 106.76%8.37M | 291.07%58M | 72.03%-22.03M | 122.41%10.19M | -223.42%-38.16M | -4,925.15%-123.67M | -556.76%-30.36M | -692.39%-78.76M | -250.74%-45.47M | 205.39%30.92M |
Net other investing changes | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 73.97%-46.52M | 257.79%52.97M | 22.06%-64.69M | 113.27%6.9M | -309.69%-41.69M | -347.02%-178.75M | -552.31%-33.57M | -307.04%-83M | -342.33%-52.01M | 71.66%-10.18M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -92.99%5.58M | 44.63%-1.22M | -95.58%3.44M | -185.05%-1M | 53.70%4.36M | 973.31%79.6M | -324.74%-2.2M | 1,451.88%77.78M | 166.05%1.18M | -11.53%2.84M |
Net issuance payments of debt | --0 | --0 | ---- | ---- | ---- | 767,541.67%92.09M | --18.34M | ---- | ---- | ---- |
Proceeds from stock option exercised by employees | -24.79%10.81M | 88.41%130K | -22.36%4.23M | -87.05%324K | -3.60%6.13M | -5.80%14.38M | -95.93%69K | -18.02%5.45M | 916.67%2.5M | -4.71%6.36M |
Net other financing activities | 80.54%-5.23M | 93.46%-1.35M | 44.12%-794K | -0.08%-1.33M | 49.84%-1.76M | -243.06%-26.87M | -2,766.48%-20.61M | 13.19%-1.42M | 34.33%-1.32M | -1.62%-3.52M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -92.99%5.58M | 44.63%-1.22M | -95.58%3.44M | -185.05%-1M | 53.70%4.36M | 973.31%79.6M | -324.74%-2.2M | 1,451.88%77.78M | 166.05%1.18M | -11.53%2.84M |
Net cash flow | ||||||||||
Beginning cash position | 3.04%214.13M | 25.59%230.11M | 31.16%244.55M | 0.05%206.38M | 3.04%214.13M | 25.93%207.8M | 8.50%183.22M | 12.20%186.45M | 45.35%206.27M | 25.93%207.8M |
Current changes in cash | 2,452.82%130.73M | 317.05%115.52M | -1,009.50%-17.29M | 298.50%38.76M | -318.30%-6.26M | -88.78%5.12M | -23.21%27.7M | -132.94%-1.56M | -171.97%-19.52M | 93.29%-1.5M |
Effect of exchange rate changes | -329.28%-2.76M | -209.87%-3.53M | 270.11%2.85M | -91.78%-583K | -4,424.24%-1.49M | 142.25%1.2M | 12.23%3.21M | 17.83%-1.67M | 89.41%-304K | 95.88%-33K |
End cash Position | 59.77%342.1M | 59.77%342.1M | 25.59%230.11M | 31.16%244.55M | 0.05%206.38M | 3.04%214.13M | 3.04%214.13M | 8.50%183.22M | 12.20%186.45M | 45.35%206.27M |
Free cash flow | 83.36%154.08M | -2.34%58.84M | 6,715.46%38.5M | 14.17%29.21M | 2,358.74%27.53M | 106.59%84.03M | 111.79%60.25M | -106.03%-582K | 2,133.47%25.58M | -131.84%-1.22M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |